Down syndrome as risk factor for respiratory syncytial virus hospitalization: A prospective multicenter epidemiological study.
dc.contributor.author | Sánchez-Luna, Manuel | |
dc.contributor.author | Medrano, Constancio | |
dc.contributor.author | Lirio, Julián | |
dc.contributor.author | RISK-21 Study Group | |
dc.date.accessioned | 2025-01-07T12:50:12Z | |
dc.date.available | 2025-01-07T12:50:12Z | |
dc.date.issued | 2016-12-30 | |
dc.description.abstract | Respiratory syncytial virus (RSV) infection in childhood, particularly in premature infants, is associated with significant morbidity and mortality. To compare the hospitalization rates due to RSV infection and severity of disease between infants with and without Down syndrome (DS) born at term and without other associated risk factors for severe RSV infection. In a prospective multicentre epidemiological study, 93 infants were included in the DS cohort and 68 matched by sex and data of birth (±1 week) and were followed up to 1 year of age and during a complete RSV season. The hospitalization rate for all acute respiratory infection was significantly higher in the DS cohort than in the non-DS cohort (44.1% vs 7.7%, P Infants with DS showed a higher rate of hospitalization due to acute lower respiratory tract infection and RSV infection compared to non-DS infants. Including DS infants in recommendations for immunoprophylaxis of RSV disease should be considered. | |
dc.identifier.doi | 10.1111/irv.12431 | |
dc.identifier.essn | 1750-2659 | |
dc.identifier.pmc | PMC5304568 | |
dc.identifier.pmid | 27611835 | |
dc.identifier.pubmedURL | https://pmc.ncbi.nlm.nih.gov/articles/PMC5304568/pdf | |
dc.identifier.unpaywallURL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/irv.12431 | |
dc.identifier.uri | https://hdl.handle.net/10668/24972 | |
dc.issue.number | 2 | |
dc.journal.title | Influenza and other respiratory viruses | |
dc.journal.titleabbreviation | Influenza Other Respir Viruses | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Torrecárdenas | |
dc.organization | SAS - Hospital Universitario Puerta del Mar | |
dc.organization | SAS - Hospital Universitario San Cecilio | |
dc.organization | SAS - Hospital Universitario Virgen de las Nieves | |
dc.organization | SAS - Hospital Universitario de Jaén | |
dc.organization | SAS - Hospital de Antequera | |
dc.organization | SAS - Hospital Universitario Regional de Málaga | |
dc.page.number | 157-164 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Multicenter Study | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Down syndrome | |
dc.subject | hospitalization | |
dc.subject | palivizumab | |
dc.subject | prospective birth cohort study | |
dc.subject | respiratory syncytial virus | |
dc.subject.mesh | Acute Disease | |
dc.subject.mesh | Antiviral Agents | |
dc.subject.mesh | Down Syndrome | |
dc.subject.mesh | Epidemiologic Studies | |
dc.subject.mesh | Female | |
dc.subject.mesh | Follow-Up Studies | |
dc.subject.mesh | Hospitalization | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Infant | |
dc.subject.mesh | Infant, Newborn | |
dc.subject.mesh | Male | |
dc.subject.mesh | Palivizumab | |
dc.subject.mesh | Prospective Studies | |
dc.subject.mesh | Respiratory Syncytial Virus Infections | |
dc.subject.mesh | Respiratory Syncytial Virus, Human | |
dc.subject.mesh | Risk Factors | |
dc.title | Down syndrome as risk factor for respiratory syncytial virus hospitalization: A prospective multicenter epidemiological study. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 11 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- PMC5304568.pdf
- Size:
- 309.5 KB
- Format:
- Adobe Portable Document Format